Wexford Capital LP Bridge Bio Pharma, Inc. Transaction History

Wexford Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $569,000 - $2.67 Million	-50,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $929,400 - $1.28 Million	20,000 Added 66.67%	50,000 $3.05 Million
Q4 2020 Feb 16, 2021	BUY	$38.38 - $71.11 $1.15 Million - $2.13 Million	30,000 New	30,000 $2.13 Million
Q1 2020 May 18, 2020	SELL	$16.11 - $36.23 $241,650 - $543,450	-15,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.96 - $46.63 $269,400 - $699,450	15,000 New	15,000 $526,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

Stay updated on Wexford Capital LP with notifications on news.